Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FTC
MedTech
FTC aims to stop Edwards’ acquisition of JenaValve
The FTC moved to block Edwards Lifesciences’ buyout of JenaValve and its heart implant for aortic regurgitation, slated for FDA approval this year.
Conor Hale
Aug 7, 2025 11:33am
Sanofi CEO does not rule out future Pompe BD despite FTC moves
Jan 10, 2024 3:37pm
Illumina sets a date to divest Grail
Dec 18, 2023 11:12am
Sanofi scraps Maze deal after FTC throws up antitrust obstacles
Dec 12, 2023 6:00am
Illumina CEO Francis deSouza resigns after proxy battle
Jun 12, 2023 10:30am
Illumina wins FTC antitrust case over Grail acquisition
Sep 1, 2022 1:50pm
